Renal haemodynamic effects of endothelin-1 and the ET(A)/ET(B) antagonist TAK-044 in anaesthetized rabbits

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 1897-1905

  Evans, Roger G ^a   Bergström, Göran ^b   Cotterill, Emma ^a   Anderson, Warwick P ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Antagonist; Endothelin; Laser doppler flowmetry; Renal cortex; Renal function; Renal medulla; TAK 044

Indexed keywords

DRUG VEHICLE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; TAK 044;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; BLOOD VESSEL REACTIVITY; CONFERENCE PAPER; EXTRACORPOREAL CIRCULATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MEDULLA; MALE; MICTURITION; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RABBIT; RENAL ARTERY; SODIUM EXCRETION; VASOMOTOR REFLEX;

EID: 0032441576     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00008     Document Type: Conference Paper

References (28)

1. Cowley AW Jr. Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol 1997; 273:R1-R15.
2. 1 agonist on renal antihypertensive mechanisms in rabbits. Am J Physiol 1998; 275:R76-R85.
3. Brooks DP. Endothelin; the 'prime suspect' in kidney disease. News Physiol Sci 1997; 12:83-89.
4. A receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats. Life Sci 1995; 58:PL1-PL7.
5. Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, et al. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Cardiovasc Res 1996; 31:499-510.
6. Haynes WG, Ferro CJ, O'Kane KPJ, Somerville D, Lomax CC, Webb DJ. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 1996; 93:1860-1870.
7. Mortensen LH, Fink GD. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension 1992; 19:549-554.
8. Wilkins FCJr, Alberola A, Mizelle HL, Opgenorth TJ, Granger JP. Chronic pathophysiologic circulating endothelin levels produce hypertension in conscious dogs. J Cardiovasc Pharmacol 1993; 22 (suppl 8):S325-S327.
9. May CN, Mathai ML, McDougall JG, Whitworth JA. Cardiovascular effects of long-term endothelin infusion and responses to endothelin during ACTH infusion in conscious sheep. Am J Hypertens 1993; 6:837-843.
10. Gurbanov K, Rubinstein I, Hoffman A, Abassi Z, Better OS, Winaver J. Differential regulation of renal regional blood flow by endothelin-1. Am J Physiol 1996; 271:F1166-F1172.
11. Tsuchiya K, Naruse M, Sanaka T, Naruse K, Nitta K, Demura H, Sugino N. Effects of endothelin on renal regional blood flow in dogs. Eur J Pharmacol 1989; 166:541-543.
12. Jones CR, Hiley CR, Pelton JT, Miller RC. Autoradiographic localisation of endothelin binding sites in kidney. Eur J Pharmacol 1989; 163:379-382.
13. Karet FE, Davenport AP. Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue. J Cardiovasc Pharmacol 1995; 26 (suppl 3):S268-S271.
14. B receptors. J Pharmacol Exp Ther 1996; 279:675-685.
15. A receptor activation. Am J Physiol 1993; 264:R222-R226.
16. Dobrowolski L, Endlich K, Sadowski J, Steinhausen M. Cardiovascular and renal effects of endothelin receptor blockade with PD 145065 and interaction with urodilatin. Acta Physiol Scand 1997; 159:7-13.
17. Matsuura T, Miura K, Ebara T, Yukimura T, Yamanaka S, Kim S, Iwao H. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats. Br J Pharmacol 1997; 122:81-86.
18. 8]vasopressin on regional kidney perfusion and renal excretory function in anesthetized rabbits. J Cardiovasc Pharmacol 1998; 32: 571-581.
19. Evans RG, Rankin AJ, Anderson WP. Interactions of blockade of nitric oxide synthase and angiotensin-converting enzyme on renal function in conscious rabbits. J Cardiovasc Pharmacol 1994; 24:542-551.
20. 2 abrogates endothelin-induced vasoconstriction in renal outer medullary descending vasa recta of the rat. J Clin Invest 1995; 95:2734-2740.
21. Änggård E, Galton S, Rae G, Thomas R, Mcloughlin L, de Nucci G, Vane JR. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 1989; 13 (suppl 5):S46-S49.
22. Thompson A, Valeri CR, Lieberthal W. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am J Physiol 1995; 269:H743-H748.
23. Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol 1996; 271:R254-R261.
24. B-receptor antagonist, in anaesthetized rats. Jpn J Pharmacol 1996; 71:213-222.
25. Braun C, Lang C, Hocher B, Gretz N, van der Woude FJ, Rohmeiss P. Influence of the renal endothelin system on the autoregulation of renal blood flow in spontaneously hypertensive rats. Kidney Blood Press Res 1997; 20:6-10.
26. A receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits. Eur J Pharmacol 1997; 321:295-300.
27. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325:997-1001.
28. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4:303-308.